Table 1.
12 h | 24 h | 36 h | 48 h | |
---|---|---|---|---|
0·5%FCS | 3·00 ± 0·05 | 3·14 ± 0·24 | 3·23 ± 0·22 | 3·01 ± 0·27 |
Nor.aIgA1 | 3·33 ± 0·21 | 3·21 ± 0·1 | 4·83 ± 0·23*† | 5·54 ± 0·43*† |
Pat.aIgA1 | 3·22 ± 0·12 | 3·42 ± 0·06 | 5·51 ± 0·15**† | 6·45 ± 0·18**† |
Supernant fibronectin concentration of HMC exposed to 0·5%FCS culture medium alone (0·5%FCS) or with aIgA1 of 100 µg/ml from healthy controls(Nor. aIgA1) or from patients with IgAN (Pat.aIgA1) for different hours. Results shown were means ± 2SE of three different experiments with triplicate wells. The cells were a mixture of six lines and the aIgA1 sample was from pooled sera of 10 healthy controls or 10 patients.
P ≤ 0·05 Nor.aIgA1 versus 0·5%FCS
P ≤ 0·05, Pat.aIgA1 versus 0·5%FCS or Nor.aIgA1
P ≤ 0·05 between different time with in the same group.